Azitra, Inc. - SIC # 2834 - PHARMACEUTICAL PREPARATIONS

Ticker Exchange SIC # Website Latest Ticker
AZTR 2834 azitrainc.com

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for Azitra, Inc.

Azitra, Inc. Announces Pricing of $1.5 Million Private Placement Priced At a Premium To Market Under NYSE Rules - Nov 24th, 2025 7:00 am
AZTR: ATR-01 Data Presented - Nov 18th, 2025 2:48 am
Azitra, Inc. Announces Q3 2025 Results and Provides Business Updates - Nov 12th, 2025 3:15 pm
Azitra, Inc. Addresses False Report Regarding Sale of Securities - Nov 7th, 2025 4:00 am
Wall Street Set to Open Higher Monday as Investors Look Ahead to a Week of Earnings Reports - Oct 20th, 2025 7:27 am
Azitra, Inc. Announces Positive Preclinical Data for ATR-01 Program, Designed to Treat Ichthyosis Vulgaris - Oct 20th, 2025 6:02 am
Azitra to Participate in Dermatologic Rare Disease Panel at Maxim Growth Summit - Oct 15th, 2025 2:05 pm
Azitra Receives Notice of Non-Compliance from NYSE American - Oct 3rd, 2025 2:45 pm
Azitra, Inc. to Present at the H.C. Wainwright 27th Annual Global Investment Conference - Sep 4th, 2025 6:10 am
Why Is Azitra (AZTR) Stock Soaring Today - Aug 27th, 2025 2:44 pm
Sector Update: Health Care Stocks Mixed Late Afternoon - Aug 27th, 2025 1:41 pm
Sector Update: Health Care Stocks Advance Wednesday Afternoon - Aug 27th, 2025 11:59 am
Azitra, Inc. Announces First Patient Dosed in Phase 1/2 Trial for ATR-04 Program Targeting Oncology Patients with EGFRi-Associated Rash - Aug 27th, 2025 6:10 am
AZTR: Second Quarter Update - Aug 25th, 2025 5:15 am
Azitra, Inc. Announces Q2 2025 Results and Provides Business Updates - Aug 11th, 2025 3:00 pm
Azitra, Inc. Announces Reverse Stock Split - Aug 11th, 2025 2:15 pm
Azitra Reports Promising Safety Data from Phase 1b Trial in Netherton Syndrome - Jun 17th, 2025 6:02 am
Azitra, Inc. Announces Presentation at the 2025 BIO International Convention - Jun 10th, 2025 6:33 am
Azitra, Inc. Announces Presentation at ASCO 2025 Highlighting Clinical Trial Investigating ATR-04 for EGFRi-Associated Rash - May 28th, 2025 6:33 am
AZTR: ATR-04 Trial to Dose 1st Patient Mid-2025 - May 21st, 2025 4:16 am